Career Center AES Connect

Resources for Providers

Treatment options for epilepsy and seizures include medications, surgery, neurostimulation devices, and dietary therapy. Antiseizure medications (ASMs) are often the first line of treatment.

 

AES Treatment-Related Resources for Epilepsy Care Providers

/
arrow_drop_down
Antiseizure Medications and Fetal Development Chart arrow_drop_down

This comprehensive chart provides an overview of the potential risks associated with antiseizure medications during pregnancy and lactation. It outlines the congenital malformation risk level (low to high), specific birth malformations, special considerations, and lactation safety recommendations for each medication. Designed for clinicians and healthcare providers, the chart supports informed decision-making and patient counseling when managing epilepsy in pregnant or breastfeeding individuals.

View the Full Chart (PDF)

Antiseizure Medications and Liver Health: A Summary of Drug-Induced Liver Injury arrow_drop_down

Understanding the impact of antiseizure medications (ASMs) on liver function is essential for clinicians treating people with epilepsy. This comprehensive resource outlines the types of drug-induced liver injury (DILI) associated with commonly used ASMs, highlights risk factors and monitoring recommendations, and provides key considerations for identifying and managing liver-related complications.

For quick reference, view our pocket guide, designed to support clinical decision-making at the point of care.

View the Full Chart (PDF)

A Summary of Antiseizure Medications Available in the United States (Updated 2024) arrow_drop_down

A tabular PDF summary of the most commonly used ASMs available for prescription in the United States. This document replaces the AES 2018 Summary of AEDs Available in the United States and the 2020 Summary of ASMs Available in the United States.

Neurostimulation Therapy for Epilepsy for Advanced Practice Providers (August 2022) arrow_drop_down
This resource is intended to provide information for APPs involved in the clinical management of VNS, RNS, and DBS devices.
AES Member Alert and Information on Ketogenic Diet Formulas (February 2022) arrow_drop_down
This summary details the discontinuation of Microlipid™ and offers alternatives for patients who use it as part of a ketogenic diet.
Treatment of Refractory Convulsive Status Epilepticus: A Comprehensive Review by the American Epilepsy Society Treatments Committee (Published 2020) arrow_drop_down
A comprehensive review that evaluates the strength of evidence for eight parenteral ASMs used as third-line treatments of convulsive refractory status epilepticus.
Over-the-Counter Drugs and Epilepsy - Considerations for providers managing patients with epilepsy with acute medical conditions. arrow_drop_down
Help your patients make informed decisions about over-the-counter medications. Explore our resource on safe options, potential risks, and key considerations for people with epilepsy.
Behavioral Health Toolkit: Screeners for Clinicians arrow_drop_down

The aim of this toolkit is to create an easy-to-use guide to inform a clinician’s selection of behavioral health screening tools to best fit both their patient population and practice scope.

 

View the Toolkit